Please login to the form below

Not currently logged in

Novartis appoints new comms chief

Michael Willi replaces Michele Galen

Swiss pharma company Novarits has named Michael Willi as its new global head of communications, effective June 1.

He replaces Michele Galen who had been in the role for two years. According to PRWeek, Galen has chosen to return to the US for family reasons.

Willi was most recently chief communications officer at the Swiss banking firm UBS, spending 15 years at the company. He left in April 2013 amid struggles among senior management related to a company restructure following major losses.

Since leaving UBS, Willi has worked as an independent consultant on communications and corporate reputation.

His appointment at Novartis marks his first role in the life sciences sector. Among his most pressing concerns will be handing the communications aspects of Novartis' recent deal to acquire the oncology portfolio of GSK and to sell its vaccines portfolio.

23rd May 2014

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...